Andreas Petri
18Patents
3h-index
32Co-inventors
56Inventor score
Filing activity: Nov 22, 2004 → Jun 30, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9879265B2 | Oligonucleotide conjugates | Chemistry; Metallurgy | 13 | Active |
| US7312062B2 | Lipolytic enzyme variants | Chemistry; Metallurgy | 7 | Expired |
| US9034837B2 | Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon | Chemistry; Metallurgy | 3 | Active |
| US10443058B2 | Antisense oligomers targeting PCSK9 | Chemistry; Metallurgy | 1 | Active |
| US10385342B2 | Methods of treatment using antisense oligomers and conjugates targeting PCSK9 | Chemistry; Metallurgy | 1 | Active |
| US10370668B2 | Manufacture of antisense oligomers and conjugates targeting PCSK9 | Chemistry; Metallurgy | 1 | Active |
| US7632669B2 | Lipolytic enzyme variants | Chemistry; Metallurgy | 1 | Active |
| US7851176B2 | Lipolytic enzyme variants | Chemistry; Metallurgy | 1 | Active |
| US8679774B2 | Lipolytic enzyme variants | Chemistry; Metallurgy | 0 | Active |
| US12421516B2 | Antisense oligomers targeting PCSK9 | Chemistry; Metallurgy | 0 | Active |
| US10301624B2 | Targeting human satellite II (HSATII) | Chemistry; Metallurgy | 0 | Active |
| US10626395B2 | Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy | Chemistry; Metallurgy | 0 | Active |
| US11091764B2 | Antisense oligomers targeting PCSK9 | Chemistry; Metallurgy | 0 | Active |
| US11739332B2 | Antisense oligomers targeting PCSK9 | Chemistry; Metallurgy | 0 | Active |
| US10787665B2 | Antisense oligomers targeting HOXB-AS3 long non-coding RNA | Chemistry; Metallurgy | 0 | Active |
| US11499152B2 | Inhibitors of micro-RNA 22 | Chemistry; Metallurgy | 0 | Active |
| US11236336B2 | Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy | Chemistry; Metallurgy | 0 | Active |
| US12152241B2 | Targeting human satellite II (HSATII) | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.